PLYGF (PolyPeptide Group AG) Common Stock: $0.4 Mil (As of Dec. 2025)


PLYGF PolyPeptide Group AG PLYGF
56 GF Score
Price $43.00
GF Value $40.45
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is PolyPeptide Group AG Common Stock?

PolyPeptide Group AG PLYGF 56 Common Stock is $0.4 Mil as of Dec. 2025. GuruFocus rates PLYGF with a GF Score™ of 56/100 and a GF Value™ of $40.45 (Fairly Valued). The stock has 8 warning signs investors should review.

PolyPeptide Group AG's quarterly common stock increased from Dec. 2024 ($0.3 Mil) to Jun. 2025 ($0.3 Mil) and increased from Jun. 2025 ($0.3 Mil) to Dec. 2025 ($0.4 Mil).

PolyPeptide Group AG's annual common stock declined from Dec. 2023 ($0.3 Mil) to Dec. 2024 ($0.3 Mil) but then increased from Dec. 2024 ($0.3 Mil) to Dec. 2025 ($0.4 Mil).

PolyPeptide Group AG Common Stock Historical Data

* Premium members only.

The historical data trend for PolyPeptide Group AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG Common Stock Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial 0.34 0.32 0.33 0.32 0.35

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.33 0.32 0.35 0.35
PLYGF
56GF Score
PolyPeptide Group AG PLYGF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPeptide Group AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.4 Mil mean?
PolyPeptide Group AG (PLYGF) has a Common Stock of $0.4 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PolyPeptide Group AG and its competitors.
Is PolyPeptide Group AG's Common Stock too high?
PolyPeptide Group AG's current Common Stock is $0.4 Mil. Overall, PolyPeptide Group AG has a GF Score™ of 56/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's Common Stock compare to ZTS and UTHR?
PolyPeptide Group AG's Common Stock of $0.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on PolyPeptide Group AG and its competitors. PolyPeptide Group AG's current Common Stock is $0.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (PLYGF) is currently considered Fairly Valued. The stock's GF Value™ is $40.45, compared to a current price of $43.00 — trading 6.3% above its estimated fair value. The current Common Stock is $0.4 Mil. PolyPeptide Group AG's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For PolyPeptide Group AG (PLYGF), the current Common Stock is $0.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (PLYGF) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of $43.00 is trading 6.3% above its estimated GF Value™ of $40.45. GuruFocus considers PolyPeptide Group AG to be Fairly Valued.

Key valuation signals for PLYGF:

  • Common Stock: $0.4 Mil
  • GF Value™: $40.45 vs. price of $43.00 (6.3% above fair value)
  • GF Score™: 56/100 with 8 warning signs

No single metric tells the full story. See the PLYGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
56GF Score

Get the complete analysis for PLYGF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$43.00
Price
$40.45
GF Value